4 latest FDA approvals

Here are the four latest medical devices or drugs approved by the U.S. Food and Drug Administration.

Advertisement
  1. Germany-basedSiemens Healthineers developed the Somatom Drive computed tomography system for use in pediatrics, cardiology, oncology and emergency medicine.
  2. Afluria is a quadrivalent flu vaccine developed by Cambridge, Mass.-based Seqirus.
  3. Switzerland-based Novartis gained approval for Erelzi, a biosimilar version of Amgen’s best-selling arthritis drug Enbrel.
  1. Flumazenil, developed by India-based Claris Lifesciences, a Claris Lifesciences Limited subsidiary, is an injectable anti-sedation medication.

More articles on supply chain:

Study: Pricey drug-coated stents don’t outperform conventional versions
How Mylan could actually boost profits from its generic EpiPen
Following inspection, Theranos withdraws FDA authorization request for Zika test

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.